Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
MoonLake Immunotherapeutics AG
Assistance Publique - Hôpitaux de Paris
Brain Inflammation Collaborative
Bristol-Myers Squibb
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Amgen
Janssen Pharmaceutica N.V., Belgium
University of California, San Diego
University of California, San Diego
Aalborg University Hospital
Sanguine Biosciences
Global Healthy Living Foundation
University of Alabama at Birmingham
Janssen Pharmaceutica N.V., Belgium
Janssen Research & Development, LLC
University of Southern Denmark
Imperial College London
University of Cagliari
AbbVie
Pfizer
Chinese University of Hong Kong